Synapse - Dmitriy Zamarin

Results (54)

Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer

Journal Article

Himoto, Y.; Veeraraghavan, H.; Zheng, J.; Zamarin, D.; Snyder, A.; Capanu, M.; Nougaret, S.; Vargas, H. A.; Shitano, F.; Callahan, M.; more...
JCO Precision Oncology (2019)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results

Meeting Abstract

Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
International Journal of Gynecological Cancer (2019)

Fulltext@MSK | Save

A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma

Meeting Abstract

Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma

Meeting Abstract

Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer

Journal Article

Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
Gynecologic Oncology (2019)

Fulltext@MSK | Save

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade

Journal Article

Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
Gynecologic Oncology (2019)

Fulltext@MSK | Save

A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission

Meeting Abstract

O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: A surveillance, epidemiology, and end results cohort study

Journal Article

Oseledchyk, A.; Gennarelli, R. L.; Leitao, M. M. Jr; Aghajanian, C. A.; Iasonos, A.; Zivanovic, O.; Zamarin, D.
Cancer Medicine (2018)

Fulltext@MSK | Save

Early clinical progression in patients with gynecologic malignancies receiving immunomodulatory antibody therapy

Meeting Abstract

Zamarin, D.; Martin, M.; Zecca, N.; Iasonos, A.; Zhou, Q.; Aghajanian, C.; Sabbatini, P.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies

Meeting Abstract

Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save